We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App





Thermo Shows New Clinical Innovations

By LabMedica International staff writers
Posted on 07 Aug 2019
Thermo Fisher Scientific Inc. More...
(Waltham, MA; USA) showcased its latest instruments, assays and software at the 71st American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (AACC 2019) held in Anaheim, California, USA, on August 4-8.

Thermo Fisher offers a range of instruments, including Class I medical devices, which provide greater sensitivity and reliability for diagnostic testing across small and large molecules and within complex biological matrices. At AACC 2019, Thermo Fisher highlighted its Cascadion SM Clinical Analyzer, which combines assays, software, accessories, consumables and support in a standalone system designed to meet the regulatory requirements for routine and specialized clinical LC-MS testing. The Cascadion SM Clinical Analyzer is currently approved for use in Europe and the company is now preparing for clinical trials for submission to the US FDA for obtaining 510(k) clearance. Thermo Fisher showcased its ImmunoCAP Allergen Components test for Furry Animal allergens that helps clinicians improve pet allergy diagnosis by analyzing sensitivity to specific proteins found in the skin, fur and saliva of dogs, cats and horses. Clinicians can better guide treatment plans by determining the primary allergen most likely causing symptoms. This helps to reduce the need to re-home pets due to owner allergies, informs more appropriate pet selection and assesses the risk of developing asthma.

The company also highlighted its Sensititre ARIS HiQ AST System, which is a benchtop automated reading and incubation system for antimicrobial susceptibility testing (AST). Thermo Fisher showcased how the system provides laboratories with the accurate minimum inhibitory concentration (MIC) results required by clinicians to confidently select effective antibiotics for patients. This capability also supports industry-wide antimicrobial stewardship efforts to reduce the use of antibiotics.

At AACC 2019, Thermo Fisher showcased its liquid chromatography and mass spectrometry offering for clinical diagnostic labs, including the Vanquish MD High Performance Liquid Chromatography (HPLC) system, TSQ Altis MD Series mass spectrometer and Quantis MD Series mass spectrometer. The company has added these new systems to its existing Prelude MD and Prelude LX-4 MD HPLC systems to form a more complete MD portfolio of analytical solutions for the diagnostic laboratory. These platforms enable clinical labs to achieve desired sensitivity and throughput goals while conforming to in vitro diagnostic (IVD) regulation. This helps ensure confidence in laboratory-developed tests (LDTs) powered by a complete suite of LDT software with a laboratory information system.

Thermo Fisher also showcased its MAS controls with enhanced LabLink XL Quality Assurance Software and Auto-Connectivity Software that offer daily quality control (QC) monitoring so clinical scientists and the medical staffs they support can more quickly and confidently access and apply results from laboratory diagnostic and prognostic tests. The MAS controls ensure adherence to clinical chemistry and immunoassay standards, enabling high daily throughput and efficiency without sacrificing quality. LabLink Software subsequently provides instant access to peer data and QC metrics without any additional work.

The company also highlighted its new easy-to-handle, sustainable plate design for prepared culture media products that supports the latest automated and manual methods for the analysis of microbiological samples for clinical, food safety testing and pharmaceutical laboratories. Fully compatible with all available automated specimen processors, the SmartPlate design brings together Oxoid and Remel prepared culture media with an enhanced universal plate format for efficient and high-throughput isolation, identification, differentiation and screening of samples. The innovative SmartPlate technology offers a sustainable assay plate design that reduces the resin materials used to manufacture each plate, as well as minimizing laboratory waste due to its advanced durability.

"Clinical laboratories play pivotal roles in healthcare as expectations increase for diagnostic speed, accuracy and cost-savings," said Patrick Durbin, senior vice president and president, specialty diagnostics for Thermo Fisher Scientific. "From more effective use of antibiotics to calls for faster lab-supported diagnoses, we're continuously advancing our portfolio to meet the new and unmet needs of healthcare providers who are working to improve patient outcomes."


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
New
Benchtop Cooler
PCR-Cooler & PCR-Rack
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.